Return-Path: <17e4a.147af198@vmail44.newsletters.email> Received: from vps.transocean.com by vps.transocean.com with LMTP id QJQAHKfyuFpfEAAAInt2oQ ; Mon, 26 Mar 2018 06:16:23 -0700 Return-path: <17e4a.147af198@vmail44.newsletters.email> Envelope-to: JOHN@TRANSOCEAN.COM Delivery-date: Mon, 26 Mar 2018 06:16:23 -0700 Received: from vmail44.newsletters.email ([67.23.183.140]:40420) by vps.transocean.com with esmtp (Exim 4.89_1) (envelope-from <17e4a.147af198@vmail44.newsletters.email>) id 1f0Ryr-0001IT-QS for JOHN@TRANSOCEAN.COM; Mon, 26 Mar 2018 06:16:23 -0700 DKIM-Signature: v=1; a=rsa-sha1; c=simple/simple; d=newsletters.email; s=dknewsletter; t=1522070141; bh=AF3EDIay4qvpvNUhZs3qBy2fHkU=; h=Date:From:Reply-To:To:Subject:List-Unsubscribe; b=dbDiT/BOgLDTPmD7ux5m9hPYahTeY3f9pZ5t1nBglJC2eA/t8hS58Na2Ec5Vr6mbf NNlpF1CntwTBuatnG8UYpinLrYyCdE2SbW0ePoGvQrrnzTI9ou6lMq3uv7v78d4dKy 4P4u2nQVkHufFTcWrlGtUOPCCxmTXGRFeFe6+PwY= Date: Mon, 26 Mar 2018 09:15:41 -0400 From: "Federal Law 42 CFR Part 2" Reply-To: "Federal Law 42 CFR Part 2" To: Subject: Substance Abuse and Confidentiality: 42 CFR Part 2 - On demand webinar Message-ID: <17e4a.147af198.3d61f9d7@vmail44.newsletters.email> X-MNB-TRACKING: c21pc2hyYSA6IEpPSE5AVFJBTlNPQ0VBTi5DT00gOiA1YWI4ZTNlMGQyNTk5YzUyMTYwN2U0OGY= X-MNB-SENDID: 5ab8e3e0d2599c521607e48f List-Unsubscribe: Feedback-ID: 2285012:2253566:newsletter:massmail Content-Type: multipart/alternative; boundary="=_5ab8f27d3D61F9D77f60c0120f507F60B808F7E0147af19817E4A" MIME-Version: 1.0 X-Spam-Status: No, score=0.2 X-Spam-Score: 2 X-Spam-Bar: / X-Ham-Report: Spam detection software, running on the system "vps.transocean.com", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Confidentiality of Substance Use Disorder Patient Records: Complying with the New Federal Law 42 CFR Part 2 Presenter Sue Dill Calloway, RN, MSN, JD, is the president of Patient Safety and Healthcare Consulting and Educatìon company with a focus on medical-legal educatìon especially Joint Commission and the CMS hospital CoPs regulatory compliance. Read more! [...] Content analysis details: (0.2 points, 3.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: newsletters.email] -0.0 RCVD_IN_MSPIKE_H2 RBL: Average reputation (+2) [67.23.183.140 listed in wl.mailspike.net] -0.0 T_RP_MATCHES_RCVD Envelope sender domain matches handover relay domain 0.2 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level mail domains are different -0.0 SPF_HELO_PASS SPF: HELO matches SPF record 0.0 T_SPF_TEMPERROR SPF: test of record failed (temperror) 0.0 HTML_MESSAGE BODY: HTML included in message -0.0 BAYES_20 BODY: Bayes spam probability is 5 to 20% [score: 0.1108] -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid X-Spam-Flag: NO This is a multi-part message in MIME format. --=_5ab8f27d3D61F9D77f60c0120f507F60B808F7E0147af19817E4A Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Disposition: inline Confidentiality of Substance Use Disorder Patient Records: Complying with t= he New Federal Law 42 CFR Part 2 =20 Presenter Sue Dill Calloway, RN, MSN, JD, is the president of Patient Safety and Heal= thcare Consulting and Educat=C3=ACon company with a focus on medical-legal = educat=C3=ACon especially Joint Commission and the CMS hospital CoPs regula= tory compliance. Read more! On Demand Webinar Tuesday, March 27, 2018 Length: 90 minutes Time: Available All Day 1.5 AAPC CEUs Approved REGISTER NOW =20 Expl=C3=B2re the New Law on Confidentiality of Substance Use Disorder Patie= nt Records Under 42 CFR Part 2 The new law on confidentiality of substance use disorder patient records un= der 42 CFR part 2 became effective in 2017. This law was previously known a= s the confidentiality of dr=C3=B9g ab=C3=B9se and alc=C3=B2hol ab=C3=B9se r= ecords. There have been further revisions to this law, effective from Febru= ary 2, 2018. The 2018 rule expands the way the protected health records (PH= I) on substance use disorder patients can be shared. It discusses when the = patient consents that substance use disorder medical records can be disclos= ed for payment or healthcare operations, the recipient listed in the consen= t form can then share the information with their contractors, sub-contracto= rs and legal representatives. It also discusses when information can be use= d for audits and evaluations. It also provides for an abbreviated notice of= the prohibition on redisclosure. The new law is a very detailed law and ho= spitals are still struggling to determine what they need to do to meet comp= liance. If a patient is admitted to a hospital to the substance use disorder treatm= ent floor, are you up to speed on how to comply with the many requirements = of this law? What is the responsibility if the patient being treated for dr= =C3=B9g or alc=C3=B2hol abus=C3=A8 discloses he or she has abused their chi= ldren? When can minors consent to treatment? When can the parents of a mino= r get acc=C3=A8ss to their records? What if the patient commits a crime on = the property? Everyone who works with substance use disorder patients, who = are subject to the new law, must understand its requirements. In this session, expert speaker Sue Dill Calloway will cover the new law on= confidentiality of substance use disorder patient records under 42 CFR par= t 2 and will provide answers to all these questions and more. This session = will discuss what is required of part 2 programs. A facility that receives = federal assistance (such as Med=C3=ACcare) and holds itself out as providin= g substance use disorder diagnos=C3=ACs, treatment, or referral must follow= this extensive regulation, which addresses the notice that must be given t= o the patient. This session will discuss the new law in detail, including p= atient acc=C3=A8ss to medical records and what must be in the consent form.= It will discuss research, closure of a program, new definitions, minors, d= eceased patient records, secur=C3=ACty of medical records, disclosure, when= disclosure is prohibited and more. Read more Session Highlights Understand that the federal law on dr=C3=B9g and alc=C3=B2hol records has b= een rewritten and is now known as confidentiality of substance use disorder= records Learn when a minor can consent to the treatment of a substance abus=C3=A8 d= isorder Understand that a spec=C3=ACal consent form is needed to release the medica= l records of a patient treated for substance abus=C3=A8 disorder in a part = 2 program Understand when a report of a violation must be reported and to whom Session Agenda Introduction and history Previously called confidentiality of dr=C3=B9g and alc=C3=B2hol records Substance use disorder patient records How to locate a copy of the law Substance use disorder data American Hospital Association recommendations Purpose and need of new law Who is subjected to the law under part 2 Federally assisted and holding one out More rules in round two Sub-regulatory guidances will be issued Notice to patients of confidentiality requirements Patient acc=C3=A8ss to medical records and restrictions on use Reports of violations or penalties General provisions Definitions Minor patient Deceased patient Secur=C3=ACty of medical records Restrictions on disclosure Crimes on the premises and child abus=C3=A8 reports Prohibitions on re-disclosure Relationship to state laws Disclosures with consent Disclosures to the criminal justice system Disclosure without consent Medical emergencies Court orders Informants and undercover agents Closing a program Research Audits and evaluation FAQs OCR and H=C3=8CPAA and mental health records And more! Offer: $30 off | Cod=C3=A8: EASTER30=20 REGISTER NOW =20 Contact Us: 1-866-458-2965 customerservice@audioeducator.com AudioEducator Reference Cod=C3=A8 : EHOSMX09_MS We hope you found this message to be useful. If you don=E2=80=99t wish to receive any further communication, please clic= k the unsubscribe link below. Your request will be processed within 10 days= .=20 This message has been sent by Audio Educator. Audio Educator - 2222 Sedwick Dr - Durham - NC - 27713 Subscribe to this newsletter: https://www.newsletters.email/tools/subscription.php?username=3Dsmishra&sen= d_id=3D5ab8e3e0d2599c521607e48f&l=3Ds&newsletter_id=3D1413404898 Unsubscribe JOHN@TRANSOCEAN.COM: https://www.newsletters.email/tools/subscription.php?username=3Dsmishra&sen= d_id=3D5ab8e3e0d2599c521607e48f&l=3Du&email=3DJOHN@TRANSOCEAN.COM Change your preferences: https://www.newsletters.email/tools/subscription.php?username=3Dsmishra&sen= d_id=3D5ab8e3e0d2599c521607e48f&l=3Dp&email=3DJOHN@TRANSOCEAN.COM Forward to a friend: https://www.newsletters.email/tools/forward.php?username=3Dsmishra&newslett= er_id=3D1413404898&send_id=3D5ab8e3e0d2599c521607e48f Report this email as spam: https://www.newsletters.email/tools/abuse_report.php?username=3Dsmishra&sen= d_id=3D5ab8e3e0d2599c521607e48f&email=3DJOHN@TRANSOCEAN.COM This email was sent using MyNewsletterBuilder.com. --=_5ab8f27d3D61F9D77f60c0120f507F60B808F7E0147af19817E4A Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Disposition: inline
 
<= font style=3D"font-size: 35px; line-height: 40px; color: #ffffff; font-fami= ly: Segoe, 'Segoe UI', 'DejaVu Sans', 'Trebuchet MS', Verdana, sans-serif;"= >Confidentiality of Substance Use Disorder Patient Records: Complyi= ng with the New Federal Law 42 CFR Part 2
&nb= sp;
Presenter
Su= e Dill Calloway, RN, MSN, JD, is the president of Patient Safety a= nd Healthcare Consulting and Educatìon company with a focus on medic= al-legal educatìon especially Joint Commission and the CMS hospital = CoPs regulatory compliance. Read more!
On Demand We= binar
Tuesday, March 27, 20= 18
Length: 90 minutes
Time: Available All Day
 1.5 AAPC CEUs Approved

Expl&ogra= ve;re the New Law on Confidentiality of Substance Use Disorder Patient Reco= rds Under 42 CFR Part 2

The new law on confiden= tiality of substance use disorder patient records under 42 CFR part 2 becam= e effective in 2017. This law was previously known as the confidentiality o= f drùg abùse and alcòhol abùse records. There h= ave been further revisions to this law, effective from February 2, 2018. Th= e 2018 rule expands the way the protected health records (PHI) on substance= use disorder patients can be shared. It discusses when the patient consent= s that substance use disorder medical records can be disclosed for payment = or healthcare operations, the recipient listed in the consent form can then= share the information with their contractors, sub-contractors and legal re= presentatives. It also discusses when information can be used for audits an= d evaluations. It also provides for an abbreviated notice of the prohibitio= n on redisclosure. The new law is a very detailed law and hospitals are sti= ll struggling to determine what they need to do to meet compliance.
If a patient is admitted to a hospital to the substance use disorder t= reatment floor, are you up to speed on how to comply with the many requirem= ents of this law? What is the responsibility if the patient being treated f= or drùg or alcòhol abusè discloses he or she has abuse= d their children? When can minors consent to treatment? When can the parent= s of a minor get accèss to their records? What if the patient commit= s a crime on the property? Everyone who works with substance use disorder p= atients, who are subject to the new law, must understand its requirements.<= br />
In this session, expert speaker Sue Dill Calloway will cover the new law on confidentiality of substance use disorder pat= ient records under 42 CFR part 2 and will provide answers to all these ques= tions and more. This session will discuss what is required of part 2 progra= ms. A facility that receives federal assistance (such as Medìcare) a= nd holds itself out as providing substance use disorder diagnosìs, t= reatment, or referral must follow this extensive regulation, which addresse= s the notice that must be given to the patient. This session will discuss t= he new law in detail, including patient accèss to medical records an= d what must be in the consent form. It will discuss research, closure of a = program, new definitions, minors, deceased patient records, securìty= of medical records, disclosure, when disclosure is prohibited and more. Read more
Session Highlights
  • Understand that the federal law on drùg and alcòhol recor= ds has been rewritten and is now known as confidentiality of substance use = disorder records
  • Learn when a minor can consent to the treatment of a substance abus&egr= ave; disorder
  • Understand that a specìal consent form is needed to release the = medical records of a patient treated for substance abusè disorder in= a part 2 program
  • Understand when a report of a violation must be reported and to whom
Session Agenda
  • Introduction and history
  • Previously called confidentiality of drùg and alcòhol rec= ords
  • Substance use disorder patient records
  • How to locate a copy of the law
  • Substance use disorder data
  • American Hospital Association recommendations
  • Purpose and need of new law
  • Who is subjected to the law under part 2
  • Federally assisted and holding one out
  • More rules in round two
  • Sub-regulatory guidances will be issued
  • Notice to patients of confidentiality requirements
  • Patient accèss to medical records and restrictions on use
  • Reports of violations or penalties
  • General provisions
  • Definitions
  • Minor patient
  • Deceased patient
  • Securìty of medical records
  • Restrictions on disclosure
  • Crimes on the premises and child abusè reports
  • Prohibitions on re-disclosure
  • Relationship to state laws
  • Disclosures with consent
  • Disclosures to the criminal justice system
  • Disclosure without consent
  • Medical emergencies
  • Court orders
  • Informants and undercover agents
  • Closing a program
  • Research
  • Audits and evaluation
  • FAQs
  • OCR and HÌPAA and mental health records
  • And more!
Offer: $30 off | Cod= è: EASTER30
   REGISTER NOW   

Contact Us:=
 1-866-458-2965=
 = customerservice@audioeducator.com
3D"AudioEducator"
Reference Codè : EHOSMX09_MS
 
W= e hope you found this message to be useful.
If you don’t wish to= receive any further communication, please click the unsubscribe link below= . Your request will be processed within 10 days.
This message has be= en sent by Audio Educator.
3D"Please

Audio Educator  •  2222 S= edwick Dr  •  Durham, NC 27713
Subscribe  • = ; Preferen= ces  •  = Send to a Friend  •  Unsubscribe  •  Report Spam
Powered by MyNewsletter= Builder
3D"Please
3D"Please
3D"Share 3D"Share 3D"More
--=_5ab8f27d3D61F9D77f60c0120f507F60B808F7E0147af19817E4A--